BB Biotech AG (BBZA.DE) XETRA

48.95

-0.55(-1.11%)

Updated at December 23 05:54PM

Currency In EUR

Valuation

Market Cap1.94B
Enterprise Value2.05B
P/E Ratio-5.69
PEG Ratio1.93
Price/Sales Ratio-14.16
Price/Book Ratio1.35
Enterprise/Revenue-14.15
Enterprise/EBITDA0

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin2.49
Operating Margin0.3

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.21

Income Statement

Revenue111.63M
Revenue/Share-3.22
Gross Profit111.63M
EBITDA80.24M
Net Income75.9M
Diluted EPS1.38

Balance Sheet

Total Cash2.16M
Total Cash/Share0.04
Total Debt0
Total Debt/Equity0
Current Ratio758.29
Book Value Per Share33.64

Price History

52-Week Change30.19
52-Week High50.2
52-Week Low25.65
Moving Average 50 Days45.8
Moving Average 200 Days36.79

Statistics

Average Volume13,408
Shares Outstanding63.38M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.8
Trailing Annual Dividend Yield3.95
Payout Ratio-0.22
Last Split Factor5:1
Last Split DateMarch 29, 2016